[an error occurred while processing this directive] | [an error occurred while processing this directive]
A study of PET-CT SUV range for dose verification in carbon ion radiation therapy
Sun Lining,Hu Weigang,Lai Songtao,Shi Leijun,Chen Junchao
Department of Radiation Oncology,Fudan University Shanghai Cancer Center;Department of Radiation Physics,Shanghai Heavy Ion Proton Hospital,Shanghai 200032,China
Abstract Objective The positron generated at the dose deposition site by using high-energy carbon ions to hit the material annihilate with the negative electron in the material to release the gamma photon. The positron-emitting isotope (PEI) distributions in the target volume are activated significantly by carbon ions. Therefore, the mean values of positron emission tomography (PET) activity could be related to the delivered doses to the clinical target volume from carbon ion. This specialty can be used for the image registration fusion of the carbon ion treatment planning computed tomography (CT) and treatment verification PET-CT. After radiation in the almost same decay period, the relationship between the different target volume and the PET-CT SUV of different every single fraction dose can be found, then the range of SUV for the radiation target could be decided. So this PET-CT standardized uptake value (SUV) range can also provide a reference for the correlation and consistency in planning target dose verification and evaluation for the clinical trial. Methods The head phantom was used as a simulation of the real human body, the 1 cc, 4 cc, and 10 cc cube volume target contouring were done in the TPS, the 90 degree fixed carbon ion beams were delivered in different single fraction effective dose of 2.5 GyE, 5 GyE, and 8 GyE. After the beam delivery, later the PET-CT scanning was performed and parameters of scanning followed the trial regulation. The MIM Maestro software was used for the image processing and fusion to determine the maximum, minimum, average, and total values of SUV in the virtual clinical target volumes for the different single fraction dose. Results The results showed that for the same target volume, the SUV range of target had an approximate linear correlation with effective dose of target (P=0.000). The same effective dose for the different target volumes got the same SUV range (P>0.05). Conclusions For the carbon ion treatment plan, the SUV range from image registration and fusion of planning CT and PET-CT after treatment can be used to make an evaluation for accuracy of the dose distribution. And this method also could be used in the hyper-fraction treatment plan. In the SUV range research of different decay periods, the similar method can be performed for the exploration.
Corresponding Authors:
Hu Weigang,Email:jackhuwg@gmail.com
Cite this article:
Sun Lining,Hu Weigang,Lai Songtao et al. A study of PET-CT SUV range for dose verification in carbon ion radiation therapy[J]. Chinese Journal of Radiation Oncology, 2017, 26(7): 781-785.
Sun Lining,Hu Weigang,Lai Songtao et al. A study of PET-CT SUV range for dose verification in carbon ion radiation therapy[J]. Chinese Journal of Radiation Oncology, 2017, 26(7): 781-785.
[1] Nutting C,DP Dearnaley,S Webb. Intensity modulated radiation therapy:a clinical review[J].Br J Radiol,2000,73(869):459-469. [2] Antonuk LE.Electronic portal imaging devices:a review and historical perspective of contemporary technologies and research[J].Phys Med Biol,2002,47(6):R31. [3] Attanasi F,Knopf A,Parodi K,et al. Extension and validation of an analytical model for in-vivo PET verification of proton therapy–a phantom and clinical study[J].Phys Med Biol,2011,56(16):5079-5098.DOI:10.1088/0031-9155/56/16/001. [4] 胡逸民,张红志,戴建荣.肿瘤放疗物理学[J].北京:北京原子能出版社,1999. Hu YM,Zhang HZ,Dia JR.Radiotherapeutical physics[J].Beijing:Beijing Atomic Energy Press,1999. [5] Parodi K,Paganetti H,Cascio E,et al. PET/CT imaging for treatment verification after proton therapy:a study with plastic phantoms and metallic implants[J].Med Phys,2007,34(2):419-435. [6] Pawelke J,Enghardt W,Haberer T,et al. In-beam PET imaging for the control of heavy-ion tumor therapy[J].IEEE Trans Nucl Sci,1997,44(7):1492-1498. [7] Parodi K,Paganetti H,Shih H,et al. Patient study on in-vivo verification of beam delivery and range using PET/CT imaging after proton therapy[J].Int J Radiat Oncol Biol Phys,2007,68(3):920-934. [8] Iseki Y,Mizuno H,Futami Y,et al. Positron camera for range verification of heavy-ion radiotherapy[J].Nucl Inst Meth Phys Res Sec A,2003,515(3):840-849. [9] Nishio T,Ogino T,Nomura K,et al. Dose-volume delivery guided proton therapy using beam on-line PET system[J].Med Phys,2006,33(11):4190-4197. [10] Zhu X,Espana S,Daartz J,et al. Monitoring proton radiation therapy with in room PET imaging[J].Phys Med Biol,2011, 56(13):4041-4057. [11] Litzenberg DW,Roberts DA,Lee MY,et al. On-line monitoring of radiotherapy beams:Experimental results with proton beams[J].Med Phys,1999,26(6):992-1006. [12] Parodi K,Enghardt W,Haberer T.In-beam PET measurements of b+-radioactivity induced by proton beams[J].Phys Med Biol,2002,47(1):21-36. [13] Parodi K,Paganetti H,Shih HA,et al. Patient study on in-vivo verification of beam delivery and range using PET/CT imaging after proton therapy[J].Int J Radiat Oncol Biol Phys,2007,68(4):920-934. [14] Nishio T,Miyatake A,Inoue K,et al. Experimental verification of proton beam monitoring in a human body by use of activity image of positron-emitting nuclei generated by nuclear fragmentation reaction[J].Radiol Phys Technol,2008,1(1):44-54.DOI:10.1007/s12194-007-0008-8. [15] Mizuno H,T Tomitani,M Kanazawa,et al. Washout measurement of radioisotope implanted by radioactive beams in the rabbit[J].Phys Med Biol,2003,48(15):2269.
2017, Vol. 26 
